Psychiatry and Behavioral Sciences

Bryan Tolliver, MD, PhD

  

        Bryan Tolliver, MD, PhD

  
SPEAKER BIO

Bryan K. Tolliver, M.D., Ph.D. is an Assistant Professor in the Clinical Neuroscience Division of the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina.  His primary clinical and research interest is in the treatment of co-occurring bipolar disorder and substance use disorders. 

Following undergraduate training at the University of North Carolina at Chapel Hill, Dr. Tolliver received a Ph.D. from the Department of Pharmacology at the University of Kentucky in 1994 and continued preclinical addiction research training as a postdoctoral fellow at the University of California, San Francisco from 1994-1999.  In 1999, he returned to the University of Kentucky College of Medicine and received his medical degree in 2003.  He completed psychiatry residency in 2007 and addiction psychiatry fellowship training in 2008, both at the Medical University of South Carolina.  He is board certified in general/adult psychiatry and addiction psychiatry and provides both outpatient and inpatient clinical services at the MUSC Institute of Psychiatry and affiliated hospitals. In addition to his research and clinical activities, Dr. Tolliver is active in didactic teaching and clinical supervision of psychiatry residents and fellows in the MUSC Drug Abuse Research Track and addiction psychiatry fellowship.

Dr. Tolliver has received fellowship and grant support from the National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).  He is currently funded by NIAAA to investigate medication treatment effects on drinking, mood, and neurocognitive outcomes in individuals with co-occurring bipolar disorder and alcohol dependence.  Dr. Tolliver presently serves on the Evidence-Based Treatment Committee of the American Academy of Addiction Psychiatry and on the Research Committee of the International Society for Bipolar Disorders.    

  
      OBJECTIVES                                                                                                                                                               
       At the completion of this session, the participant will be able to:
       

1.  Discuss the prevalence and clinical impact of comorbidity of alcohol dependence in persons with bipolar disorder.
2.  Describe current treatment options for co-occurring alcohol dependence and bipolar disorder.
3.  Discuss the evidence for dysregulation of glutamate neurotransmission in alcohol dependence and bipolar disorder.

       

« back to January calendar

 
 
 

© 2014  Medical University of South Carolina | Disclaimer